EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Restoration of Genetic Code in Macular Mouse Fibroblasts via APOBEC1-Mediated RNA Editing

Sonali Bhakta iD, Hiroko Kodama, Masakazu Mimaki, Toshifumi Tsukahara iD

Biomolecules · 2025

DOI: 10.3390/biom15010136 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Sonali Bhakta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Bioscience, Biotechnology and Biomedical Engineering Research Area, Japan Advanced Institute of Science and Technology, Nomi 923-1211, Japan. Hauptthemen laut MEDLINE: APOBEC-1 Deaminase, RNA Editing, Fibroblasts. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RNA editing is a significant mechanism underlying genetic variation and protein molecule alteration; C-to-U RNA editing, specifically, is important in the regulation of mammalian genetic diversity. The ability to define and limit accesses of enzymatic machinery to avoid the modification of unintended targets is key to the success of RNA editing. Identification of the core component of the apoB RNA editing holoenzyme, APOBEC, and investigation into new candidate genes encoding other elements of the complex could reveal further details regarding APOBEC-mediated mRNA editing. Menkes disease is a recessive X-chromosome-linked hereditary syndrome in humans, caused by defective copper metabolism due to mutations in the ATP7A gene, which encodes a copper transport protein. Here, we generated plasmids encoding the MS2 system and the APOBEC1 deaminase domain and used a guide RNA with flanking MS2 sites to restore mutated Atp7a in fibroblasts from a macular mouse model of Menkes disease withs T>C mutation. Around 35% of the mutated C nucleotide (nt) was restored to U, demonstrating that our RNA editing system is reliable and has potential for therapeutic clinical application. RNA base editing via human RNA-guided cytidine deaminases is a potentially attractive approach for in vivo therapeutic application and provides opportunities for new developments in this field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

APOBEC-1 DeaminaseRNA EditingFibroblastsAnimalsMiceHumansMutationDisease Models, Animal

Stichwörter der Autor:innen

APOBEC 1MS2 systemRNA editingfibroblastguide RNAmacular mouse

Substanzen

APOBEC-1 DeaminaseApobec1 protein, mouse

Autor:innen und Institutionen

  • Bioscience, Biotechnology and Biomedical Engineering Research Area, Japan Advanced Institute of Science and Technology, Nomi 923-1211, Japan.
  • Department of Anatomy and Histology, Faculty of Veterinary Science, Bangladesh Agricultural University, Mymensingh 2202, Bangladesh.
  • General Medical Education and Research Center, Teikyo University School of Medicine, Tokyo 173-0003, Japan.
  • Department of Pediatrics, Teikyo University School of Medicine, Tokyo 173-0003, Japan.
  • GeCoRT Co., Ltd., Nishi-ku, Yokohama 220-0011, Japan.

ORCID-Profile: Sonali Bhakta, Toshifumi Tsukahara

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Bhakta, S., Kodama, H., Mimaki, M., & Tsukahara, T. (2025). Restoration of Genetic Code in Macular Mouse Fibroblasts via APOBEC1-Mediated RNA Editing. Biomolecules. https://doi.org/10.3390/biom15010136

Vancouver

Bhakta S, Kodama H, Mimaki M, Tsukahara T. Restoration of Genetic Code in Macular Mouse Fibroblasts via APOBEC1-Mediated RNA Editing. Biomolecules. 2025. doi:10.3390/biom15010136

BibTeX
@article{Bhakta2025,
  author = {Bhakta, Sonali and Kodama, Hiroko and Mimaki, Masakazu and Tsukahara, Toshifumi},
  title = {Restoration of Genetic Code in Macular Mouse Fibroblasts via APOBEC1-Mediated RNA Editing},
  journal = {Biomolecules},
  year = {2025},
  doi = {10.3390/biom15010136}
}
Kostenlos starten →